What does a high LDL to HDL ratio mean?

A high LDL to HDL ratio indicates increased cardiovascular disease risk, with ratios above 2.5 considered elevated. This imbalance between "bad" and "good" cholesterol requires lifestyle changes and possibly medication to reduce heart disease risk.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the LDL to HDL Ratio

Your cholesterol numbers tell an important story about your cardiovascular health, but looking at individual values only gives you part of the picture. The ratio between your LDL (low-density lipoprotein) and HDL (high-density lipoprotein) cholesterol provides crucial insight into your heart disease risk that goes beyond what either number reveals alone.

LDL cholesterol, often called "bad" cholesterol, carries cholesterol from your liver to cells throughout your body. When levels get too high, LDL can deposit cholesterol in your artery walls, forming plaques that narrow blood vessels and increase heart attack and stroke risk. HDL cholesterol, the "good" cholesterol, works in reverse, collecting excess cholesterol from your tissues and arteries and returning it to your liver for disposal.

The LDL to HDL ratio represents the balance between these opposing forces in your cardiovascular system. A high ratio means you have proportionally more artery-clogging LDL compared to protective HDL, creating an environment where cholesterol accumulation in your arteries is more likely to occur. Understanding your ratio helps you and your healthcare provider assess your cardiovascular risk more accurately than looking at either number in isolation.

LDL to HDL Ratio Risk Categories

Ratio RangeRisk CategoryCardiovascular RiskRecommended Action
Below 2.0Below 2.0OptimalLow riskMaintain healthy lifestyle
2.0-2.52.0-2.5GoodBelow average riskContinue preventive measures
2.5-3.52.5-3.5ModerateModerate riskImplement lifestyle changes
Above 3.5Above 3.5HighHigh riskAggressive intervention needed

Risk categories based on American Heart Association guidelines and clinical research.

What Is Considered a High LDL to HDL Ratio?

Medical professionals use specific thresholds to determine whether your LDL to HDL ratio falls within a healthy range or indicates increased cardiovascular risk. Understanding these ranges helps you interpret your test results and take appropriate action to protect your heart health.

Optimal vs. High Ratio Ranges

For most adults, an LDL to HDL ratio below 2.5 is considered optimal, indicating a healthy balance between bad and good cholesterol. Ratios between 2.5 and 3.5 suggest moderate risk, while ratios above 3.5 indicate high cardiovascular risk. Some cardiologists prefer even stricter targets, recommending ratios below 2.0 for individuals with existing heart disease or multiple risk factors.

To calculate your ratio, simply divide your LDL cholesterol by your HDL cholesterol. For example, if your LDL is 130 mg/dL and your HDL is 40 mg/dL, your ratio would be 3.25, placing you in the moderate risk category. This same LDL level with an HDL of 65 mg/dL would yield a ratio of 2.0, demonstrating how HDL levels significantly impact your overall risk profile.

Gender and Age Considerations

Women typically have higher HDL levels than men, especially before menopause, which often results in more favorable LDL to HDL ratios. After menopause, however, HDL levels tend to decrease while LDL levels increase, potentially worsening the ratio. Men generally need to be more vigilant about their ratios throughout adulthood, as they naturally tend toward lower HDL levels.

Age also plays a role in cholesterol ratios. As we get older, LDL levels typically rise while HDL levels may decline, particularly if we become less active. This natural progression makes regular cholesterol monitoring increasingly important with age, allowing for early intervention when ratios begin trending in an unfavorable direction.

Health Risks Associated with High LDL to HDL Ratios

A high LDL to HDL ratio significantly increases your risk of developing cardiovascular disease through multiple mechanisms. When you have too much LDL relative to HDL, your body struggles to clear cholesterol from your bloodstream efficiently, leading to a cascade of problems that can affect your entire cardiovascular system.

Atherosclerosis and Plaque Formation

The primary concern with a high LDL to HDL ratio is accelerated atherosclerosis, the process by which cholesterol plaques form in your artery walls. With insufficient HDL to remove excess cholesterol, LDL particles have more opportunity to penetrate artery walls and trigger inflammation. This inflammatory response causes white blood cells to engulf the LDL, forming foam cells that become the foundation of arterial plaques.

Over time, these plaques grow larger and can rupture, triggering blood clots that may completely block blood flow. When this occurs in coronary arteries, it causes a heart attack; in brain arteries, it leads to stroke. Studies show that people with LDL to HDL ratios above 3.5 have nearly double the risk of experiencing a cardiovascular event compared to those with ratios below 2.0.

Metabolic and Inflammatory Effects

Beyond direct arterial damage, a high LDL to HDL ratio often indicates broader metabolic dysfunction. This imbalance frequently occurs alongside insulin resistance, chronic inflammation, and oxidative stress, creating a perfect storm for cardiovascular disease development. High LDL levels promote the production of inflammatory molecules, while low HDL levels reduce your body's anti-inflammatory capacity.

Research has also linked unfavorable cholesterol ratios to increased risk of peripheral artery disease, where narrowed arteries reduce blood flow to your limbs, and to higher rates of cognitive decline, as the brain relies heavily on healthy blood flow for optimal function. The systemic nature of these effects underscores why addressing cholesterol imbalances is crucial for overall health, not just heart health.

Common Causes of Elevated LDL to HDL Ratios

Understanding what drives an unfavorable LDL to HDL ratio helps you identify which factors you can modify to improve your cardiovascular health. While some causes are genetic and beyond your control, many result from lifestyle choices that you can change with proper guidance and commitment.

Dietary and Lifestyle Factors

Diet plays a central role in determining your cholesterol ratio. Consuming high amounts of saturated fats from red meat, full-fat dairy, and processed foods increases LDL production, while trans fats found in many fried and packaged foods both raise LDL and lower HDL. Conversely, diets low in soluble fiber, omega-3 fatty acids, and plant sterols miss opportunities to naturally improve cholesterol balance.

Physical inactivity significantly worsens cholesterol ratios by reducing HDL levels and allowing LDL to accumulate. Regular exercise, particularly aerobic activities like brisk walking, swimming, or cycling, can increase HDL by 5-10% while modestly reducing LDL. Smoking delivers a double blow to your ratio by lowering HDL and making LDL more likely to damage artery walls. Even secondhand smoke exposure can negatively impact your cholesterol balance.

Medical Conditions and Medications

Several medical conditions directly affect your LDL to HDL ratio. Type 2 diabetes and metabolic syndrome typically feature low HDL and high triglycerides, which often correlate with elevated LDL. Hypothyroidism slows your metabolism, reducing your body's ability to clear LDL from the bloodstream. Chronic kidney disease and liver disorders can also disrupt normal cholesterol metabolism.

Certain medications may inadvertently worsen your cholesterol ratio. Some diuretics, beta-blockers, and corticosteroids can raise LDL or lower HDL as side effects. Anabolic steroids dramatically reduce HDL levels, sometimes by 50% or more. If you're taking medications that affect cholesterol, discuss alternatives with your healthcare provider, especially if you already have cardiovascular risk factors. Regular monitoring becomes even more important when you're on medications that can impact your lipid profile.

Testing and Monitoring Your Cholesterol Ratio

Regular cholesterol testing provides the data you need to track your LDL to HDL ratio over time and assess whether your lifestyle changes or treatments are working effectively. Understanding when and how to test, along with what additional markers to consider, empowers you to take control of your cardiovascular health.

When and How Often to Test

The American Heart Association recommends that adults over 20 have their cholesterol checked every 4-6 years if they have no risk factors. However, if you have a family history of heart disease, diabetes, or other risk factors, annual testing is more appropriate. Once you've identified an unfavorable ratio, more frequent monitoring every 3-6 months helps track your progress as you implement lifestyle changes or begin medication.

Cholesterol testing requires a blood draw, traditionally done after a 9-12 hour fast, though some newer tests don't require fasting. The standard lipid panel measures total cholesterol, LDL, HDL, and triglycerides, from which your various cholesterol ratios can be calculated. For the most accurate results, maintain your normal diet and activity patterns in the days leading up to the test, and avoid alcohol for at least 24 hours beforehand.

Advanced Testing Options

While the basic lipid panel provides valuable information, advanced testing can offer deeper insights into your cardiovascular risk. Apolipoprotein B (ApoB) testing measures the number of LDL particles, which some research suggests is a better predictor of heart disease than LDL cholesterol alone. The ApoB to ApoA1 ratio provides another way to assess the balance between atherogenic and protective lipoproteins.

Particle size testing distinguishes between large, fluffy LDL particles (less harmful) and small, dense LDL particles (more likely to penetrate artery walls). Lipoprotein(a) testing identifies genetic risk factors that standard cholesterol tests miss. These advanced markers can be particularly helpful if you have a strong family history of heart disease or if your standard cholesterol numbers don't seem to match your overall risk profile.

Strategies to Improve Your LDL to HDL Ratio

Improving your LDL to HDL ratio requires a two-pronged approach: lowering LDL while simultaneously raising HDL. The good news is that many interventions benefit both goals, and even modest improvements can significantly reduce your cardiovascular risk.

Dietary Modifications for Better Ratios

The Mediterranean diet pattern has consistently shown impressive results for improving cholesterol ratios. This approach emphasizes olive oil, nuts, fatty fish, whole grains, and abundant fruits and vegetables while limiting red meat and processed foods. Studies show this dietary pattern can improve the LDL to HDL ratio by 10-15% within just a few months.

Specific foods deserve special mention for their ratio-improving properties. Soluble fiber from oats, beans, and psyllium can lower LDL by 5-10%. Fatty fish rich in omega-3s like salmon and mackerel raise HDL while reducing triglycerides. Plant sterols found in fortified foods and supplements can lower LDL by up to 10%. Replacing saturated fats with monounsaturated fats from avocados, nuts, and olive oil improves both LDL and HDL levels.

Exercise and Lifestyle Changes

Regular aerobic exercise is one of the most effective ways to raise HDL cholesterol. Aim for at least 150 minutes of moderate-intensity exercise weekly, such as brisk walking, or 75 minutes of vigorous exercise like running. High-intensity interval training (HIIT) appears particularly effective at improving cholesterol ratios. Resistance training also helps, especially when combined with aerobic exercise.

Weight loss, even modest amounts, can significantly improve your ratio. Losing just 5-10% of body weight typically raises HDL by 5 mg/dL and lowers LDL proportionally more. Quitting smoking can increase HDL by up to 10% within weeks. Moderate alcohol consumption (one drink daily for women, two for men) may raise HDL, but the risks often outweigh benefits, especially if you have other health conditions.

Medical Interventions

When lifestyle changes aren't sufficient, medications can help achieve healthy cholesterol ratios. Statins remain the first-line treatment, potentially lowering LDL by 30-50% while modestly raising HDL. Newer medications like PCSK9 inhibitors can reduce LDL by up to 60% in people who don't respond adequately to statins or can't tolerate them.

For raising HDL specifically, options are more limited. Niacin can increase HDL by 15-35%, but side effects often limit its use. Fibrates modestly raise HDL while primarily targeting triglycerides. Your healthcare provider will consider your overall risk profile, including your LDL to HDL ratio, when determining whether medication is appropriate and which option best suits your needs.

Taking Action on Your Cholesterol Health

A high LDL to HDL ratio serves as an important warning sign that your cardiovascular system needs attention. While the increased risk is real, the power to improve your ratio lies largely in your hands through dietary choices, physical activity, and other lifestyle modifications. Even if you require medication, these lifestyle factors remain crucial for optimal outcomes.

Remember that improving your cholesterol ratio is a marathon, not a sprint. Small, sustainable changes often produce better long-term results than drastic short-term efforts. Work with your healthcare provider to establish realistic goals, monitor your progress regularly, and adjust your approach as needed. With consistent effort and proper monitoring, you can achieve a healthier cholesterol balance and significantly reduce your risk of cardiovascular disease.

References

  1. Millán, J., Pintó, X., Muñoz, A., et al. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed]
  2. Calling, S., Johansson, S. E., Wolff, M., et al. (2021). The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women's Health in the Lund Area (WHILA) - a 17-year follow-up cohort study. BMC Cardiovascular Disorders, 21(1), 163.[PubMed][DOI]
  3. Quispe, R., Elshazly, M. B., Zhao, D., et al. (2020). Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. European Journal of Preventive Cardiology, 27(15), 1597-1605.[PubMed][DOI]
  4. Arnett, D. K., Blumenthal, R. S., Albert, M. A., et al. (2019). 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation, 140(11), e596-e646.[PubMed][DOI]
  5. Estruch, R., Ros, E., Salas-Salvadó, J., et al. (2018). Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts. New England Journal of Medicine, 378(25), e34.[PubMed][DOI]
  6. Mann, S., Beedie, C., & Jimenez, A. (2014). Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Medicine, 44(2), 211-221.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my LDL to HDL ratio at home?

You can test your LDL to HDL ratio at home with SiPhox Health's Apob Advanced Cholesterol Panel, which includes LDL-C, HDL-C, and other key cardiovascular markers. For ongoing monitoring, the Heart & Metabolic Program provides regular testing to track your progress over time.

What is the ideal LDL to HDL ratio?

The ideal LDL to HDL ratio is below 2.5, with many cardiologists recommending below 2.0 for optimal heart health. Ratios between 2.5-3.5 indicate moderate risk, while ratios above 3.5 suggest high cardiovascular risk.

Can I improve my LDL to HDL ratio without medication?

Yes, many people can improve their ratio through lifestyle changes including adopting a Mediterranean-style diet, exercising regularly (150+ minutes weekly), losing excess weight, quitting smoking, and managing stress. These changes can improve ratios by 10-20% or more.

How quickly can I see improvements in my cholesterol ratio?

Dietary changes can begin improving your ratio within 4-6 weeks, while exercise benefits may take 8-12 weeks to fully manifest. Most healthcare providers recommend retesting after 3 months of lifestyle changes to assess progress.

Is the LDL to HDL ratio more important than individual cholesterol numbers?

The ratio provides valuable additional context beyond individual numbers, as it reflects the balance between harmful and protective cholesterol. However, very high LDL or very low HDL levels are concerning regardless of ratio, so both individual values and ratios matter for comprehensive assessment.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details